Health Condition 1: O00-O9A- Pregnancy, childbirth and the puerperium
Conditions
Interventions
Intervention1: Group A: Aspirin 75 mg: Women in this group will receive aspirin 75mg one tablet daily throughout the pregnancy and to stop taking tablets at 36 weeks of gestation or earlier in the eve
Sponsors
Dr RPGMC Kangra at Tanda
Eligibility
Inclusion criteria
Inclusion criteria: Age more than equal to 18 years and less than equal to 40 years Singleton pregnancy Live fetus at the gestational age of 12 to 28 weeks High or moderate risk of developing pre eclampsia as per ACOG Atleast 1 high risk factor namely History of pre eclampsia Diabetes mellitus type 1 or 2 Chronic hypertension Chronic kidney disease Autoimmune disease Multi fetal gestation Combination of multiple moderate risk factors Or Atleast 2 or more of the following moderate risk factors including Obesity pre pregnancy BMI more than equal to 30 Advanced maternal age more than equal to 35 years Family history of pre eclampsia Nulliparity First degree relative with pre eclampsia Conception after in vitro fertilization
Exclusion criteria
Exclusion criteria: Allergy to aspirin Asthma Peptic ulcers History of alcohol or drug abuse within 6 months Previous registration in another drug trial within the previous 3 months
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Prevention of pre eclampsia Timepoint: Before 34 weeks of gestation 34 to 36 weeks 6 days of gestation At or after 37 weeks of gestation | — |
Secondary
| Measure | Time frame |
|---|---|
| Comparison of feto maternal outcomes between the two groupsTimepoint: Before 37 weeks & after 37 weeks | — |
Countries
India
Contacts
Public ContactDr Ajay Sood
Dr RPGMC Kangra at Tanda
Outcome results
None listed